Your browser doesn't support javascript.
loading
Neoadjuvant Therapy Versus Upfront Surgery for Patients With Clinical Stage 2 or 3 Esophageal Squamous Cell Carcinoma: A Cost-Effectiveness Analysis.
Gao, Xing; Wen, Yu-Wen; van Lanschot, Joseph Jan Baptist; Chao, Yin-Kai.
Afiliação
  • Gao X; Division of Thoracic Surgery, Chang Gung Memorial Hospital-Linkou, Chang Gung University, Taoyuan, Taiwan.
  • Wen YW; Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.
  • van Lanschot JJB; Division of Thoracic Surgery, Chang Gung Memorial Hospital-Linkou, Chang Gung University, Taoyuan, Taiwan.
  • Chao YK; Clinical Informatics and Medical Statistics Research Center, Chang Gung University, Taoyuan, Taiwan.
Ann Surg Oncol ; 29(6): 3644-3653, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35018592

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article